Vertex Pharmaceuticals sees early success with Journavx painkiller, potential revenue growth from drug and gene therapy.

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

Morgan Stanley raised the firm’s price target on Vertex (VERX) to $60 from $57 and keeps an Overweight rating on the shares. The company’s first investor day showcased how multiple secular ...

She was selected to coordinate the suite slated for delivery to Reiner Gamma with the Lunar Vertex. The Lunar Vertex is a joint lander and rover payload suite. Joel Kearns, Deputy Associate ...

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...

From placing your monitor at the right height to clearing space for your mouse, follow our tips to tidy your desk and optimize your productivity. I've been contributing to PCMag since 2011 in a ...

KING OF PRUSSIA, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) today announced that it will host an Investor Day on Wednesday, March 19, in Philadelphia, PA. The event will ...

It could be a simple wall calendar found in many kitchens and bedrooms, or around your offices. It could also be found on a desk blotter or similar item. Each helps keep track of the day ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Starting Monday, users can add events to a Google Calendar directly from an email. Gemini will automatically detect calendar-related content in an email and present an “Add to calendar” button.

Well thanks very much, everyone, for joining us for our next session with Vertex. My name is Dave Risinger ... how many per se make the switch in this calendar year, but we will be reporting ...